drugset / Trial / NCT01842503
Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent
Phase 1/2
Completed
25 enrolled
Laboratorio Farmaceutico Ct S.r.l.
Latis S.r.l. · collabQuotient Bioresearch · collabVoisin Consulting, Inc. · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
Examination of the effect of GET 73 on alcohol pharmacokinetics and pharmacodynamics (intoxication and sedation)and safety profile in alcohol-dependent individuals.To evaluate whether GET 73, as compared to placebo, results in diminished cue-reactivity responses to alcohol cues in terms of urge to drink during the cue reactivity session and results in lower quantity of alcohol consumed during an alcohol self-administration session.
Timeline
- Start
- 2014-11
- Primary completion
- 2018-11
- Completion
- 2018-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | GET73 | Small molecule | 300 mg | — |